Compounds > dichlororibofuranosylbenzimidazole
Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Hypercalcemia

dichlororibofuranosylbenzimidazole has been researched along with Hypercalcemia in 1 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Hypercalcemia: Abnormally high level of calcium in the blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benítez-Verguizas, J1
Esbrit, P1

Other Studies

1 other study available for dichlororibofuranosylbenzimidazole and Hypercalcemia

ArticleYear
Proliferative effect of parathyroid hormone-related protein on the hypercalcemic Walker 256 carcinoma cell line.
    Biochemical and biophysical research communications, 1994, Feb-15, Volume: 198, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Animals; Antibodies; Bucladesine; Calcium; Carcinoma

1994